114 related articles for article (PubMed ID: 33235997)
21. Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis.
Husson O; van Steenbergen LN; Koldewijn EL; Poortmans PM; Coebergh JW; Janssen-Heijnen ML
BJU Int; 2014 Nov; 114(5):691-7. PubMed ID: 24131890
[TBL] [Abstract][Full Text] [Related]
22. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
23. Cerebellar large B-cell lymphoma: a case report.
Ghannam M; Mansour S; Jumah F; Berry B; Beard A
J Med Case Rep; 2018 Nov; 12(1):341. PubMed ID: 30446015
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
[TBL] [Abstract][Full Text] [Related]
25. Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994-2013).
Fuentes-Raspall R; Solans M; Auñon-Sanz C; Saez M; Marcos-Gragera R
Clin Transl Oncol; 2018 Dec; 20(12):1628-1630. PubMed ID: 29796994
[No Abstract] [Full Text] [Related]
26. Treatment of primary central nervous system lymphoma in the elderly.
Hoang-Xuan K; Chinot OL; Taillandier L
Semin Oncol; 2003 Dec; 30(6 Suppl 19):53-7. PubMed ID: 14765387
[TBL] [Abstract][Full Text] [Related]
27. Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy.
Sasaki N; Kobayashi K; Saito K; Shimizu S; Suzuki K; Lee J; Yamagishi Y; Shibahara J; Takayama N; Shiokawa Y; Nagane M
Jpn J Clin Oncol; 2020 Sep; 50(9):999-1008. PubMed ID: 32469065
[TBL] [Abstract][Full Text] [Related]
28. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
29. Primary central nervous system lymphoma.
Gallop-Evans E
Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):329-38. PubMed ID: 22459053
[TBL] [Abstract][Full Text] [Related]
30. Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016.
Posthuma HLA; Zijlstra JM; Visser O; Lugtenburg PJ; Kersten MJ; Dinmohamed AG
Br J Haematol; 2020 Apr; 189(1):117-121. PubMed ID: 31682006
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and neuroimage characteristics of primary central nervous system lymphoma].
Ding XP; Wang JY; Yuan XR; Peng ZF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):451-3. PubMed ID: 16134603
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
33. [Primary central nervous system lymphoma following immunotherapy for metastatic melanoma].
Castel M; Cotten C; Deschamps-Huvier A; Commin MH; Marguet F; Jardin F; Duval-Modeste AB; Joly P
Ann Dermatol Venereol; 2019 Oct; 146(10):634-639. PubMed ID: 31122751
[TBL] [Abstract][Full Text] [Related]
34. Post-transplantation primary central nervous system lymphoma in a patient with systemic lupus erythematosus and prolonged use of immunosuppressant.
Tse TP; Chan AN; Chan TK; Po YC
Hong Kong Med J; 2014 Dec; 20(6):541-4. PubMed ID: 25488034
[TBL] [Abstract][Full Text] [Related]
35. Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006.
Chihara D; Ito H; Izutsu K; Hattori M; Nishino Y; Ioka A; Matsuda T; Ito Y
Int J Cancer; 2015 Sep; 137(5):1217-23. PubMed ID: 25694231
[TBL] [Abstract][Full Text] [Related]
36. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
O'Brien PC; Roos DE; Liew KH; Trotter GE; Barton MB; Walker QJ; Poulsen MG; Olver IN
Med J Aust; 1996 Oct; 165(8):424-7. PubMed ID: 8913243
[TBL] [Abstract][Full Text] [Related]
37. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system lymphoma.
Stern JI; Raizer JJ
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of primary central nervous system lymphoma: the role of chemotherapy].
Maeda Y; Matsumoto K; Kuriyama M; Ono Y; Kunishio K; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1997 May; 24(7):807-13. PubMed ID: 9170518
[TBL] [Abstract][Full Text] [Related]
40. Incidence of primary cancer of the central nervous system in southeastern Netherlands during the period 1980-94. Specialists in neuro-oncology in southeastern Netherlands.
van der Sanden GA; Schouten LJ; Coebergh JW
Cancer Causes Control; 1998 Mar; 9(2):225-8. PubMed ID: 9578300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
